HEADER TRANSFERASE/TRANSFERASE INHIBITOR 21-JUN-17 5W85 TITLE CRYSTAL STRUCTURE OF IRAK-4 WITH A 4,6-DIAMINONICOTINAMIDE INHIBITOR TITLE 2 (COMPOUND NUMBER 9) COMPND MOL_ID: 1; COMPND 2 MOLECULE: INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 154-460; COMPND 5 SYNONYM: IRAK-4,RENAL CARCINOMA ANTIGEN NY-REN-64; COMPND 6 EC: 2.7.11.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: IRAK4; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS SERINE/THREONINE PROTEIN KINASE, TRANSFERASE, TRANSFERASE-TRANSFERASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.S.SACK REVDAT 2 25-OCT-17 5W85 1 JRNL REVDAT 1 11-OCT-17 5W85 0 JRNL AUTH R.S.BHIDE,A.KEON,C.WEIGELT,J.S.SACK,R.J.SCHMIDT,S.LIN, JRNL AUTH 2 H.Y.XIAO,S.H.SPERGEL,J.KEMPSON,W.J.PITTS,J.CARMAN,M.A.POSS JRNL TITL DISCOVERY AND STRUCTURE-BASED DESIGN OF JRNL TITL 2 4,6-DIAMINONICOTINAMIDES AS POTENT AND SELECTIVE IRAK4 JRNL TITL 3 INHIBITORS. JRNL REF BIOORG. MED. CHEM. LETT. V. 27 4908 2017 JRNL REFN ESSN 1464-3405 JRNL PMID 28947151 JRNL DOI 10.1016/J.BMCL.2017.09.029 REMARK 2 REMARK 2 RESOLUTION. 2.25 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.25 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.72 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.1 REMARK 3 NUMBER OF REFLECTIONS : 35437 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.227 REMARK 3 R VALUE (WORKING SET) : 0.227 REMARK 3 FREE R VALUE : 0.251 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 2.200 REMARK 3 FREE R VALUE TEST SET COUNT : 780 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 18 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.25 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.31 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 71.70 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2200 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2531 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2160 REMARK 3 BIN R VALUE (WORKING SET) : 0.2528 REMARK 3 BIN FREE R VALUE : 0.2696 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 1.82 REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4417 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 62 REMARK 3 SOLVENT ATOMS : 107 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 48.75 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 65.66 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 9.58400 REMARK 3 B22 (A**2) : -24.27780 REMARK 3 B33 (A**2) : 14.69370 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.340 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.267 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.204 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.269 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.207 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.913 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.910 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4554 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 6149 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1607 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 131 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 693 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4554 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 593 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 5351 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.12 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.88 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.91 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5W85 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-JUN-17. REMARK 100 THE DEPOSITION ID IS D_1000228588. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-FEB-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X29A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 (DENZO) REMARK 200 DATA SCALING SOFTWARE : HKL-2000 (SCALEPACK) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 35556 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.250 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.9 REMARK 200 DATA REDUNDANCY : 7.900 REMARK 200 R MERGE (I) : 0.05700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 34.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.25 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.33 REMARK 200 COMPLETENESS FOR SHELL (%) : 72.2 REMARK 200 DATA REDUNDANCY IN SHELL : 5.10 REMARK 200 R MERGE FOR SHELL (I) : 0.35200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.02 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.86 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 44.22000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 62.78000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 70.66500 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 44.22000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 62.78000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 70.66500 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 44.22000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 62.78000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 70.66500 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 44.22000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 62.78000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 70.66500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 156 REMARK 465 ALA A 157 REMARK 465 MET A 158 REMARK 465 GLY A 159 REMARK 465 VAL A 160 REMARK 465 SER A 161 REMARK 465 ASP A 162 REMARK 465 THR A 163 REMARK 465 GLY A 195 REMARK 465 ALA A 216 REMARK 465 ALA A 217 REMARK 465 MET A 218 REMARK 465 VAL A 219 REMARK 465 ASP A 220 REMARK 465 ILE A 221 REMARK 465 THR A 222 REMARK 465 THR A 223 REMARK 465 GLU A 337 REMARK 465 LYS A 338 REMARK 465 PHE A 339 REMARK 465 ALA A 340 REMARK 465 GLN A 341 REMARK 465 ALA A 459 REMARK 465 SER A 460 REMARK 465 GLY B 156 REMARK 465 ALA B 157 REMARK 465 MET B 158 REMARK 465 GLY B 159 REMARK 465 VAL B 160 REMARK 465 SER B 161 REMARK 465 ASP B 162 REMARK 465 THR B 163 REMARK 465 GLY B 195 REMARK 465 GLY B 196 REMARK 465 ALA B 216 REMARK 465 ALA B 217 REMARK 465 MET B 218 REMARK 465 VAL B 219 REMARK 465 ASP B 220 REMARK 465 ILE B 221 REMARK 465 THR B 222 REMARK 465 THR B 223 REMARK 465 GLU B 337 REMARK 465 LYS B 338 REMARK 465 PHE B 339 REMARK 465 ALA B 340 REMARK 465 SER B 460 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 164 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 225 CG CD OE1 OE2 REMARK 470 HIS A 286 CG ND1 CD2 CE1 NE2 REMARK 470 ARG B 164 CG CD NE CZ NH1 NH2 REMARK 470 PHE B 180 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ASP B 181 CG OD1 OD2 REMARK 470 ARG B 183 CG CD NE CZ NH1 NH2 REMARK 470 ILE B 185 CG1 CG2 CD1 REMARK 470 VAL B 187 CG1 CG2 REMARK 470 GLU B 194 CG CD OE1 OE2 REMARK 470 PHE B 197 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLU B 225 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 181 106.90 -57.57 REMARK 500 ASN A 206 -109.29 69.23 REMARK 500 ARG A 310 -4.43 78.83 REMARK 500 ASP A 311 50.05 -146.60 REMARK 500 ASP A 329 92.17 62.24 REMARK 500 ARG A 347 76.91 72.45 REMARK 500 ASP A 405 23.62 -77.47 REMARK 500 GLU A 406 20.04 46.76 REMARK 500 LYS A 417 31.24 -83.23 REMARK 500 ASP B 181 101.98 -57.33 REMARK 500 GLU B 182 40.94 -65.43 REMARK 500 ARG B 310 -3.31 78.17 REMARK 500 ASP B 311 49.89 -147.31 REMARK 500 ASP B 329 91.76 63.48 REMARK 500 ARG B 347 84.14 104.01 REMARK 500 ASP B 405 23.96 -77.35 REMARK 500 GLU B 406 20.43 46.10 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 9YS A 4000 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 9YS B 4000 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5W86 RELATED DB: PDB REMARK 900 RELATED ID: 5W84 RELATED DB: PDB DBREF 5W85 A 160 460 UNP Q9NWZ3 IRAK4_HUMAN 36 336 DBREF 5W85 B 160 460 UNP Q9NWZ3 IRAK4_HUMAN 36 336 SEQADV 5W85 GLY A 156 UNP Q9NWZ3 EXPRESSION TAG SEQADV 5W85 ALA A 157 UNP Q9NWZ3 EXPRESSION TAG SEQADV 5W85 MET A 158 UNP Q9NWZ3 EXPRESSION TAG SEQADV 5W85 GLY A 159 UNP Q9NWZ3 EXPRESSION TAG SEQADV 5W85 GLY B 156 UNP Q9NWZ3 EXPRESSION TAG SEQADV 5W85 ALA B 157 UNP Q9NWZ3 EXPRESSION TAG SEQADV 5W85 MET B 158 UNP Q9NWZ3 EXPRESSION TAG SEQADV 5W85 GLY B 159 UNP Q9NWZ3 EXPRESSION TAG SEQRES 1 A 305 GLY ALA MET GLY VAL SER ASP THR ARG PHE HIS SER PHE SEQRES 2 A 305 SER PHE TYR GLU LEU LYS ASN VAL THR ASN ASN PHE ASP SEQRES 3 A 305 GLU ARG PRO ILE SER VAL GLY GLY ASN LYS MET GLY GLU SEQRES 4 A 305 GLY GLY PHE GLY VAL VAL TYR LYS GLY TYR VAL ASN ASN SEQRES 5 A 305 THR THR VAL ALA VAL LYS LYS LEU ALA ALA MET VAL ASP SEQRES 6 A 305 ILE THR THR GLU GLU LEU LYS GLN GLN PHE ASP GLN GLU SEQRES 7 A 305 ILE LYS VAL MET ALA LYS CYS GLN HIS GLU ASN LEU VAL SEQRES 8 A 305 GLU LEU LEU GLY PHE SER SER ASP GLY ASP ASP LEU CYS SEQRES 9 A 305 LEU VAL TYR VAL TYR MET PRO ASN GLY SER LEU LEU ASP SEQRES 10 A 305 ARG LEU SER CYS LEU ASP GLY THR PRO PRO LEU SER TRP SEQRES 11 A 305 HIS MET ARG CYS LYS ILE ALA GLN GLY ALA ALA ASN GLY SEQRES 12 A 305 ILE ASN PHE LEU HIS GLU ASN HIS HIS ILE HIS ARG ASP SEQRES 13 A 305 ILE LYS SER ALA ASN ILE LEU LEU ASP GLU ALA PHE THR SEQRES 14 A 305 ALA LYS ILE SER ASP PHE GLY LEU ALA ARG ALA SER GLU SEQRES 15 A 305 LYS PHE ALA GLN TPO VAL MET TPO SEP ARG ILE VAL GLY SEQRES 16 A 305 THR THR ALA TYR MET ALA PRO GLU ALA LEU ARG GLY GLU SEQRES 17 A 305 ILE THR PRO LYS SER ASP ILE TYR SER PHE GLY VAL VAL SEQRES 18 A 305 LEU LEU GLU ILE ILE THR GLY LEU PRO ALA VAL ASP GLU SEQRES 19 A 305 HIS ARG GLU PRO GLN LEU LEU LEU ASP ILE LYS GLU GLU SEQRES 20 A 305 ILE GLU ASP GLU GLU LYS THR ILE GLU ASP TYR ILE ASP SEQRES 21 A 305 LYS LYS MET ASN ASP ALA ASP SER THR SER VAL GLU ALA SEQRES 22 A 305 MET TYR SER VAL ALA SER GLN CYS LEU HIS GLU LYS LYS SEQRES 23 A 305 ASN LYS ARG PRO ASP ILE LYS LYS VAL GLN GLN LEU LEU SEQRES 24 A 305 GLN GLU MET THR ALA SER SEQRES 1 B 305 GLY ALA MET GLY VAL SER ASP THR ARG PHE HIS SER PHE SEQRES 2 B 305 SER PHE TYR GLU LEU LYS ASN VAL THR ASN ASN PHE ASP SEQRES 3 B 305 GLU ARG PRO ILE SER VAL GLY GLY ASN LYS MET GLY GLU SEQRES 4 B 305 GLY GLY PHE GLY VAL VAL TYR LYS GLY TYR VAL ASN ASN SEQRES 5 B 305 THR THR VAL ALA VAL LYS LYS LEU ALA ALA MET VAL ASP SEQRES 6 B 305 ILE THR THR GLU GLU LEU LYS GLN GLN PHE ASP GLN GLU SEQRES 7 B 305 ILE LYS VAL MET ALA LYS CYS GLN HIS GLU ASN LEU VAL SEQRES 8 B 305 GLU LEU LEU GLY PHE SER SER ASP GLY ASP ASP LEU CYS SEQRES 9 B 305 LEU VAL TYR VAL TYR MET PRO ASN GLY SER LEU LEU ASP SEQRES 10 B 305 ARG LEU SER CYS LEU ASP GLY THR PRO PRO LEU SER TRP SEQRES 11 B 305 HIS MET ARG CYS LYS ILE ALA GLN GLY ALA ALA ASN GLY SEQRES 12 B 305 ILE ASN PHE LEU HIS GLU ASN HIS HIS ILE HIS ARG ASP SEQRES 13 B 305 ILE LYS SER ALA ASN ILE LEU LEU ASP GLU ALA PHE THR SEQRES 14 B 305 ALA LYS ILE SER ASP PHE GLY LEU ALA ARG ALA SER GLU SEQRES 15 B 305 LYS PHE ALA GLN TPO VAL MET TPO SEP ARG ILE VAL GLY SEQRES 16 B 305 THR THR ALA TYR MET ALA PRO GLU ALA LEU ARG GLY GLU SEQRES 17 B 305 ILE THR PRO LYS SER ASP ILE TYR SER PHE GLY VAL VAL SEQRES 18 B 305 LEU LEU GLU ILE ILE THR GLY LEU PRO ALA VAL ASP GLU SEQRES 19 B 305 HIS ARG GLU PRO GLN LEU LEU LEU ASP ILE LYS GLU GLU SEQRES 20 B 305 ILE GLU ASP GLU GLU LYS THR ILE GLU ASP TYR ILE ASP SEQRES 21 B 305 LYS LYS MET ASN ASP ALA ASP SER THR SER VAL GLU ALA SEQRES 22 B 305 MET TYR SER VAL ALA SER GLN CYS LEU HIS GLU LYS LYS SEQRES 23 B 305 ASN LYS ARG PRO ASP ILE LYS LYS VAL GLN GLN LEU LEU SEQRES 24 B 305 GLN GLU MET THR ALA SER MODRES 5W85 TPO A 342 THR MODIFIED RESIDUE MODRES 5W85 TPO A 345 THR MODIFIED RESIDUE MODRES 5W85 SEP A 346 SER MODIFIED RESIDUE MODRES 5W85 TPO B 342 THR MODIFIED RESIDUE MODRES 5W85 TPO B 345 THR MODIFIED RESIDUE MODRES 5W85 SEP B 346 SER MODIFIED RESIDUE HET TPO A 342 11 HET TPO A 345 11 HET SEP A 346 10 HET TPO B 342 11 HET TPO B 345 11 HET SEP B 346 10 HET 9YS A4000 31 HET 9YS B4000 31 HETNAM TPO PHOSPHOTHREONINE HETNAM SEP PHOSPHOSERINE HETNAM 9YS 6-[(1,3-BENZOTHIAZOL-6-YL)AMINO]-4-{[(2S)-1-HYDROXY-3- HETNAM 2 9YS PHENYLPROPAN-2-YL]AMINO}-N-METHYLPYRIDINE-3- HETNAM 3 9YS CARBOXAMIDE HETSYN TPO PHOSPHONOTHREONINE HETSYN SEP PHOSPHONOSERINE FORMUL 1 TPO 4(C4 H10 N O6 P) FORMUL 1 SEP 2(C3 H8 N O6 P) FORMUL 3 9YS 2(C23 H23 N5 O2 S) FORMUL 5 HOH *107(H2 O) HELIX 1 AA1 SER A 169 THR A 177 1 9 HELIX 2 AA2 PRO A 184 GLY A 188 5 5 HELIX 3 AA3 GLU A 225 CYS A 240 1 16 HELIX 4 AA4 SER A 269 SER A 275 1 7 HELIX 5 AA5 CYS A 276 THR A 280 5 5 HELIX 6 AA6 SER A 284 ASN A 305 1 22 HELIX 7 AA7 LYS A 313 ALA A 315 5 3 HELIX 8 AA8 THR A 351 MET A 355 5 5 HELIX 9 AA9 ALA A 356 GLY A 362 1 7 HELIX 10 AB1 PRO A 366 GLY A 383 1 18 HELIX 11 AB2 LEU A 397 ASP A 405 1 9 HELIX 12 AB3 THR A 409 TYR A 413 5 5 HELIX 13 AB4 ASP A 422 LEU A 437 1 16 HELIX 14 AB5 LYS A 440 ARG A 444 5 5 HELIX 15 AB6 ASP A 446 THR A 458 1 13 HELIX 16 AB7 SER B 169 THR B 177 1 9 HELIX 17 AB8 GLU B 225 CYS B 240 1 16 HELIX 18 AB9 SER B 269 SER B 275 1 7 HELIX 19 AC1 CYS B 276 THR B 280 5 5 HELIX 20 AC2 SER B 284 ASN B 305 1 22 HELIX 21 AC3 LYS B 313 ALA B 315 5 3 HELIX 22 AC4 THR B 351 MET B 355 5 5 HELIX 23 AC5 ALA B 356 GLY B 362 1 7 HELIX 24 AC6 PRO B 366 GLY B 383 1 18 HELIX 25 AC7 LEU B 395 LEU B 397 5 3 HELIX 26 AC8 ASP B 398 ASP B 405 1 8 HELIX 27 AC9 THR B 409 TYR B 413 5 5 HELIX 28 AD1 ASP B 422 LEU B 437 1 16 HELIX 29 AD2 LYS B 440 ARG B 444 5 5 HELIX 30 AD3 ASP B 446 ALA B 459 1 14 SHEET 1 AA1 6 HIS A 166 SER A 167 0 SHEET 2 AA1 6 LEU A 248 SER A 252 1 O LEU A 249 N HIS A 166 SHEET 3 AA1 6 CYS A 259 VAL A 263 -1 O VAL A 261 N LEU A 249 SHEET 4 AA1 6 THR A 208 LYS A 214 -1 N ALA A 211 O TYR A 262 SHEET 5 AA1 6 VAL A 199 VAL A 205 -1 N TYR A 201 O VAL A 212 SHEET 6 AA1 6 LYS A 191 GLY A 193 -1 N MET A 192 O VAL A 200 SHEET 1 AA2 2 HIS A 307 ILE A 308 0 SHEET 2 AA2 2 ARG A 334 ALA A 335 -1 O ARG A 334 N ILE A 308 SHEET 1 AA3 2 ILE A 317 LEU A 319 0 SHEET 2 AA3 2 ALA A 325 ILE A 327 -1 O LYS A 326 N LEU A 318 SHEET 1 AA4 2 VAL A 343 MET A 344 0 SHEET 2 AA4 2 GLU A 363 ILE A 364 -1 O ILE A 364 N VAL A 343 SHEET 1 AA5 6 HIS B 166 SER B 167 0 SHEET 2 AA5 6 LEU B 248 SER B 252 1 O PHE B 251 N HIS B 166 SHEET 3 AA5 6 LEU B 258 VAL B 263 -1 O VAL B 261 N LEU B 249 SHEET 4 AA5 6 THR B 208 LEU B 215 -1 N LEU B 215 O LEU B 258 SHEET 5 AA5 6 VAL B 199 VAL B 205 -1 N TYR B 201 O VAL B 212 SHEET 6 AA5 6 LYS B 191 GLY B 193 -1 N MET B 192 O VAL B 200 SHEET 1 AA6 2 HIS B 307 ILE B 308 0 SHEET 2 AA6 2 ARG B 334 ALA B 335 -1 O ARG B 334 N ILE B 308 SHEET 1 AA7 2 ILE B 317 LEU B 319 0 SHEET 2 AA7 2 ALA B 325 ILE B 327 -1 O LYS B 326 N LEU B 318 SHEET 1 AA8 2 VAL B 343 MET B 344 0 SHEET 2 AA8 2 GLU B 363 ILE B 364 -1 O ILE B 364 N VAL B 343 LINK C TPO A 342 N VAL A 343 1555 1555 1.34 LINK C MET A 344 N TPO A 345 1555 1555 1.34 LINK C TPO A 345 N SEP A 346 1555 1555 1.33 LINK C SEP A 346 N ARG A 347 1555 1555 1.34 LINK C GLN B 341 N TPO B 342 1555 1555 1.35 LINK C TPO B 342 N VAL B 343 1555 1555 1.34 LINK C MET B 344 N TPO B 345 1555 1555 1.34 LINK C TPO B 345 N SEP B 346 1555 1555 1.33 LINK C SEP B 346 N ARG B 347 1555 1555 1.34 CISPEP 1 GLU A 392 PRO A 393 0 0.99 CISPEP 2 GLU B 392 PRO B 393 0 1.58 SITE 1 AC1 14 GLY A 193 GLU A 194 VAL A 200 ALA A 211 SITE 2 AC1 14 LYS A 213 TYR A 262 VAL A 263 TYR A 264 SITE 3 AC1 14 MET A 265 PRO A 266 GLY A 268 ASP A 272 SITE 4 AC1 14 LEU A 318 HOH A4126 SITE 1 AC2 14 MET B 192 GLY B 193 GLU B 194 VAL B 200 SITE 2 AC2 14 ALA B 211 TYR B 262 VAL B 263 TYR B 264 SITE 3 AC2 14 MET B 265 PRO B 266 GLY B 268 ASP B 272 SITE 4 AC2 14 LEU B 318 HOH B4126 CRYST1 88.440 125.560 141.330 90.00 90.00 90.00 I 2 2 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011307 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007964 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007076 0.00000